"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...

In recent years, the medical community, researchers, and health policy makers have increasingly recognized that many long-established and widely used clinical decision-making tools actually perpetuate ...

MISSION HILLS, LOS ANGELES (KABC) -- A medical test for kidney function that adjusts its results for race is coming under increased scrutiny. Experts are saying the results for African-American ...

A race-specific algorithm designed to assess kidney function for individuals awaiting transplants jeopardized critical treatment for some Black Americans. An exclusive report by the Associated Press ...

EGFR mutation testing is crucial for NSCLC treatment, but global disparities exist in access to comprehensive molecular diagnostics. Third-generation inhibitors and combination regimens improve ...

The FINANCIAL — Insights from experts working on-the-ground in lung cancer, compiled by Boehringer Ingelheim, shed light on challenges faced by patients with advanced stage adenocarcinoma, a type of ...

DEAR DR. ROACH: I am a 73-year-old female. A recent blood test returned an eGFR (estimated glomerular filtration rate) of 59. My physician’s nurse told me that the test was normal. When I asked her ...

May 14, 2008 — The blocking of epidermal growth-factor receptors (EGFR) to treat non-small-cell lung cancer is becoming increasingly common, but there is considerable debate about when to initiate ...

CHICAGO -- There is new hope for thousands of African Americans waiting for a new kidney. A test to determine placement on a transplant waiting list has been deemed flawed. The finding will have a ...

Despite the fact that albuminuria represents a key risk factor for chronic kidney disease (CKD), even in the absence of reduced filtration, testing for the condition is low among adult patients with ...